目的系统性评价左氧氟沙星和质子泵抑制剂(PPI)三联疗法治疗幽门螺杆菌(HP)的疗效和不良反应发生率。
Objective To systematically assess the effectiveness and adverse reaction rates of levofloxacin PPI triple therapy in the treatment of Helicobacter pylori (HP).
当患者需氧抗炎镇痛治疗会有高风险的复发性溃疡出血，应该接受环氧化酶-2（COX-2）抑制剂和质子泵抑制剂的联合治疗。
Patients at very high risk for recurrent ulcer bleeding who need anti-inflammatory analgesics should receive combination treatment with a COX 2 inhibitor and a PPI.
处方的警告和注意事项，非处方质子泵抑制剂的药品事实说明书将对这些结果进行说明。
Both the Warnings and Precautions section of the prescription labeling and the Drug Facts label on OTC proton pump inhibitors will address these findings.
应用推荐